{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:39:27Z","timestamp":1785843567250,"version":"3.56.0"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Neutralizing antibodies are assumed to be essential for protection against mumps virus infection, but their measurement is labor- and time-intensive. For this reason, enzyme-linked immunosorbent assays (ELISAs) are typically used to measure mumps-specific IgG levels. However, since there is poor correlation between mumps neutralization titers and ELISAs that measure the presence of mumps-specific IgG levels, ELISAs that better correlate with neutralization are needed. To address this issue, we measured mumps antibody levels by plaque reduction neutralization, by a commercial ELISA (whole-virus antigen), and by ELISAs specific for the mumps nucleoprotein and hemagglutinin. The results indicate that differences in the antibody response to the individual mumps proteins could partially explain the lack of correlation among various serologic tests. Furthermore, the data indicate that some seropositive individuals have low levels of neutralizing antibody. If neutralizing antibody is important for protection, this suggests that previous estimates of immunity based on whole-virus ELISAs may be overstated.<\/jats:p>","DOI":"10.1128\/cvi.00621-13","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T02:33:56Z","timestamp":1388111636000},"page":"286-297","source":"Crossref","is-referenced-by-count":36,"title":["Estimates of Mumps Seroprevalence May Be Influenced by Antibody Specificity and Serologic Method"],"prefix":"10.1128","volume":"21","author":[{"given":"Donald R.","family":"Latner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"McGrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobia J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun B.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"key20180919073723_B1","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","article-title":"Mumps resurgences in the United States: a historical perspective on unexpected elements","volume":"27","author":"Barskey","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073723_B2","first-page":"125","article-title":"Update: mumps outbreak\u2014New York and New Jersey, June 2009\u2013January 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073723_B3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/jmv.21557","article-title":"Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September\u2013December 2006","volume":"81","author":"Rota","year":"2009","journal-title":"J. Med. Virol."},{"key":"key20180919073723_B4","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1016\/j.vaccine.2008.04.075","article-title":"Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students\u2014Iowa, 2006","volume":"26","author":"Marin","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073723_B5","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.vaccine.2010.02.020","article-title":"Mumps outbreak in a highly vaccinated student population, the Netherlands, 2004","volume":"28","author":"Brockhoff","year":"2010","journal-title":"Vaccine"},{"key":"key20180919073723_B6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3201\/eid1301.060649","article-title":"Vaccine effectiveness estimates, 2004\u20132005 mumps outbreak, England","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"key20180919073723_B7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1503\/cmaj.060660","article-title":"Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults","volume":"175","author":"Watson-Creed","year":"2006","journal-title":"CMAJ"},{"key":"key20180919073723_B8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/INF.0b013e3181d743df","article-title":"Mumps outbreak in the Republic of Moldova, 2007\u20132008","volume":"29","author":"Schwarz","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"50","key":"key20180919073723_B9","doi-asserted-by":"crossref","first-page":"pii=19440","DOI":"10.2807\/ese.14.50.19440-en","article-title":"Mumps outbreak in Jerusalem affecting mainly male adolescents","volume":"14","author":"Stein-Zamir","year":"2009","journal-title":"Euro Surveill."},{"key":"key20180919073723_B10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073723_B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268812001136","article-title":"Seroepidemiology of mumps in Europe (1996\u20132008): why do outbreaks occur in highly vaccinated populations?","volume":"12","author":"Eriksen","year":"2012","journal-title":"Epidemiol. Infect."},{"key":"key20180919073723_B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5365\/WPSAR.2012.3.4.012","article-title":"Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012","volume":"3","author":"Man","year":"2012","journal-title":"Western Pac. Surveill. Response J."},{"key":"key20180919073723_B13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1128\/JVI.06125-11","article-title":"Recent mumps outbreaks in vaccinated populations: no evidence of immune escape","volume":"86","author":"Rubin","year":"2012","journal-title":"J. Virol."},{"key":"key20180919073723_B14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1086\/590115","article-title":"Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak","volume":"198","author":"Rubin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073723_B15","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1016\/j.vaccine.2005.10.050","article-title":"Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains","volume":"24","author":"Rubin","year":"2006","journal-title":"Vaccine"},{"key":"key20180919073723_B16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jmv.1890450104","article-title":"Symptomatic mumps virus reinfections","volume":"45","author":"Gut","year":"1995","journal-title":"J. Med. Virol."},{"key":"key20180919073723_B17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/jmv.21106","article-title":"Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification","volume":"80","author":"Yoshida","year":"2008","journal-title":"J. Med. Virol."},{"key":"key20180919073723_B18","volume-title":"Vaccines","author":"Plotkin","year":"2008","edition":"5th ed."},{"key":"key20180919073723_B19","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMoa1202865","article-title":"Mumps outbreak in Orthodox Jewish communities in the United States","volume":"367","author":"Barskey","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"key20180919073723_B20","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/infdis\/jir526","article-title":"Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity","volume":"204","author":"Cortese","year":"2011","journal-title":"J. Infect. Dis."},{"key":"key20180919073723_B21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.7943","article-title":"Mumps outbreaks in highly vaccinated populations: what makes good even better?","volume":"5","author":"Vandermeulen","year":"2009","journal-title":"Hum. Vaccin."},{"key":"key20180919073723_B22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJM196702022760502","article-title":"Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation","volume":"276","author":"Hilleman","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"key20180919073723_B23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3181\/00379727-165-40967","article-title":"Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines","volume":"165","author":"Weibel","year":"1980","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"key20180919073723_B24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/infdis\/119.6.654","article-title":"Immunity to mumps in an institutional epidemic. Correlation of insusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies","volume":"119","author":"Ennis","year":"1969","journal-title":"J. Infect. Dis."},{"key":"key20180919073723_B25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/1045-1056(90)90009-O","article-title":"Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus","volume":"18","author":"Christenson","year":"1990","journal-title":"Biologicals"},{"key":"key20180919073723_B26","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","article-title":"Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays","volume":"43","author":"Mauldin","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073723_B27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3181\/00379727-125-32278","article-title":"Comparison of neutralization and hemagglutination-inhibition techniques for measuring mumps antibody","volume":"125","author":"Buynak","year":"1967","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"key20180919073723_B28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF01639028","article-title":"Comparison of five different tests for mumps antibodies","volume":"8","author":"Berger","year":"1980","journal-title":"Infection"},{"key":"key20180919073723_B29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/CDLI.00199-05","article-title":"Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus","volume":"13","author":"Backhouse","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073723_B30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-0934(99)00019-1","article-title":"Assay of humoral immunity to mumps virus","volume":"79","author":"Pipkin","year":"1999","journal-title":"J. Virol. Methods"},{"key":"key20180919073723_B31","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/588197","article-title":"Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population","volume":"197","author":"Date","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073723_B32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10156-011-0358-3","article-title":"Antibodies against mumps virus component proteins","volume":"18","author":"Matsubara","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"key20180919073723_B33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10096-011-1216-z","article-title":"Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?","volume":"30","author":"Allwinn","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"key20180919073723_B34","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/JCM.25.9.1653-1658.1987","article-title":"Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity","volume":"25","author":"Linde","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073723_B35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1128\/CVI.00284-10","article-title":"Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis","volume":"18","author":"Latner","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073723_B36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"key20180919073723_B37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/655394","article-title":"Seroprevalence of antibody to mumps virus in the US population, 1999\u20132004","volume":"202","author":"Kutty","year":"2010","journal-title":"J. Infect. Dis."},{"key":"key20180919073723_B38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1128\/JCM.00844-09","article-title":"Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection","volume":"48","author":"Ramanakumar","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073723_B39","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/JCM.30.11.2874-2880.1992","article-title":"Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays","volume":"30","author":"Hummel","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073723_B40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JVI.53.3.727-734.1985","article-title":"Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis","volume":"53","author":"Wolinsky","year":"1985","journal-title":"J. Virol."},{"key":"key20180919073723_B41","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.4049\/jimmunol.132.5.2622","article-title":"The reactions of monoclonal antibodies with structural proteins of mumps virus","volume":"132","author":"Orvell","year":"1984","journal-title":"J. Immunol."},{"key":"key20180919073723_B42","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1016\/j.vaccine.2008.08.074","article-title":"Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination","volume":"26","author":"Cohen","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073723_B43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J. Virol. Methods"},{"key":"key20180919073723_B44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1590\/S0036-46651999000100005","article-title":"Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement","volume":"41","author":"Goncalves","year":"1999","journal-title":"Rev. Inst. Med. Trop. Sao Paulo."},{"key":"key20180919073723_B45","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1016\/j.vaccine.2008.06.028","article-title":"ELISA underestimates measles antibody seroprevalence in US military recruits","volume":"26","author":"Mancuso","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073723_B46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-0934(99)00143-3","article-title":"Evaluation of different measles IgG assays based on recombinant proteins using a panel of low-titre sera","volume":"84","author":"Hartter","year":"2000","journal-title":"J. Virol. Methods"},{"key":"key20180919073723_B47","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/596207","article-title":"Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia","volume":"135","author":"Tischer","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"key20180919073723_B48","first-page":"1","article-title":"Measles prevention","volume":"38","author":"Centers for Disease Control (CDC)","year":"1989","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073723_B49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1086\/596207","article-title":"Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"199","author":"LeBaron","year":"2009","journal-title":"J. Infect. Dis."},{"key":"key20180919073723_B50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.39.3.363","article-title":"Live attenuated mumps virus vaccine. II. Early clinical studies","volume":"39","author":"Stokes","year":"1967","journal-title":"Pediatrics"},{"key":"key20180919073723_B51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/jama.1968.03140010016003","article-title":"Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration","volume":"203","author":"Weibel","year":"1968","journal-title":"JAMA"},{"key":"key20180919073723_B52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1542\/peds.51.3.467","article-title":"Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines","volume":"51","author":"Weibel","year":"1973","journal-title":"Pediatrics"},{"key":"key20180919073723_B53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.1967.03130130021005","article-title":"Vaccination of adults with live attenuated mumps virus vaccine","volume":"201","author":"Davidson","year":"1967","journal-title":"JAMA"},{"key":"key20180919073723_B54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4049\/jimmunol.71.2.76","article-title":"Studies on the prevention of mumps. VI. The relationship of neutralizing antibodies to the determination of susceptibility and to the evaluation of immunization procedures","volume":"71","author":"Bashe","year":"1953","journal-title":"J. Immunol."},{"key":"key20180919073723_B55","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/INF.0b013e318279f593","article-title":"Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control\u2014Guam 2009 to 2010","volume":"32","author":"Nelson","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073723_B56","doi-asserted-by":"publisher","first-page":"e1567","DOI":"10.1542\/peds.2012-0177","article-title":"Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak","volume":"130","author":"Ogbuanu","year":"2012","journal-title":"Pediatrics"},{"key":"key20180919073723_B57","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3201\/eid1909.130299","article-title":"Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA","volume":"19","author":"Fiebelkorn","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"key20180919073723_B58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2567.2010.03263.x","article-title":"Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice","volume":"131","author":"Vandermeulen","year":"2010","journal-title":"Immunology"},{"key":"key20180919073723_B59","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"key20180919073723_B60","doi-asserted-by":"publisher","first-page":"9929","DOI":"10.1128\/JVI.01154-12","article-title":"Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization","volume":"86","author":"Johnson","year":"2012","journal-title":"J. Virol."},{"key":"key20180919073723_B61","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.1128\/JVI.00713-09","article-title":"The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization","volume":"83","author":"Johnson","year":"2009","journal-title":"J. Virol."},{"key":"key20180919073723_B62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JVI.51.1.208-214.1984","article-title":"Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo","volume":"51","author":"Lefrancois","year":"1984","journal-title":"J. Virol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00621-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T09:02:33Z","timestamp":1688893353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00621-13"}},"subtitle":[],"editor":[{"given":"R. L.","family":"Hodinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,26]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,2,26]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1128\/CVI.00621-13"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00621-13","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,26]]}}}